Zeo ScientifiX Overview
- Year Founded
-
2011
- Status
-
Public
- Employees
-
33
- Stock Symbol
-
ZEOX
- Investments
-
1
- Share Price
-
$0.80
- (As of Friday Closing)
Zeo ScientifiX General Information
Description
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
Contact Information
Website
www.zeoscientifix.comCorporate Office
- Nova Southeastern University Center for Collaborative Research,3300 South University Drive
- Suite 246
- Fort Lauderdale, FL 33328
- United States
Corporate Office
- Nova Southeastern University Center for Collaborative Research,3300 South University Drive
- Suite 246
- Fort Lauderdale, FL 33328
- United States
Zeo ScientifiX Stock Performance
As of 13-Nov-2026, Zeo ScientifiX’s stock price is $0.80. Its current market cap is $6.24M with 7.84M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.80 | $0.80 | $0.75 - $2.99 | $6.24M | 7.84M | 6.69K | -$0.58 |
Zeo ScientifiX Financials Summary
As of 30-Apr-2026, Zeo ScientifiX has a trailing 12-month revenue of $6.99M.
|
In Thousands, USD |
TTM 30-Apr-2026 | FY 2025 31-Oct-2025 | FY 2024 31-Oct-2024 | FY 2023 31-Oct-2023 |
|---|---|---|---|---|
| EV | 14,407 | 12,754 | 10,773 | 13,054 |
| Revenue | 6,987 | 5,199 | 4,620 | 4,558 |
| EBITDA | (3,732) | (5,350) | (4,539) | (6,070) |
| Net Income | (3,884) | (5,521) | (4,705) | (6,987) |
| Total Assets | 3,886 | 1,527 | 1,643 | 2,782 |
| Total Debt | 343 | 353 | 693 | 693 |
Zeo ScientifiX Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Zeo ScientifiX Comparisons
Industry
Financing
Details
Zeo ScientifiX Competitors (5)
One of Zeo ScientifiX’s 5 competitors is Kimera Labs, a Corporation company based in Miramar, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kimera Labs | Corporation | Miramar, FL | ||||
| Alector | Formerly VC-backed | South San Francisco, CA | ||||
| Denali Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Invitrx Therapeutics | Corporation | Austin, TX | ||||
| Direct Biologics | Venture Capital-Backed | Austin, TX |
Zeo ScientifiX Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Zeo ScientifiX Patents
Zeo ScientifiX Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3242248-A1 | Compositions and methods for treating pain with extracellular vesicles | Pending | 08-Dec-2021 | ||
| US-12213994-B2 | Compositions and methods for treating pain with extracellular vesicles | Active | 08-Dec-2021 | ||
| US-20230277588-A1 | Compositions and methods for treating pain with extracellular vesicles | Active | 08-Dec-2021 | ||
| WO-2023108044-A1 | Compositions and methods for treating pain with extracellular vesicles | Inactive | 08-Dec-2021 | ||
| AU-2021253889-A1 | Compositions comprising nanoparticles, method of making and uses thereof | Inactive | 10-Apr-2020 | A61K35/50 |
Zeo ScientifiX Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Zeo ScientifiX Investments (1)
Zeo ScientifiX’s most recent deal was a Corporate with Exotropin. The deal was made on 01-Jan-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Exotropin | 01-Jan-2023 | Corporate | Other Pharmaceuticals and Biotechnology |
Zeo ScientifiX ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Zeo ScientifiX FAQs
-
When was Zeo ScientifiX founded?
Zeo ScientifiX was founded in 2011.
-
Where is Zeo ScientifiX headquartered?
Zeo ScientifiX is headquartered in Fort Lauderdale, FL.
-
What is the size of Zeo ScientifiX?
Zeo ScientifiX has 33 total employees.
-
What industry is Zeo ScientifiX in?
Zeo ScientifiX’s primary industry is Biotechnology.
-
Is Zeo ScientifiX a private or public company?
Zeo ScientifiX is a Public company.
-
What is Zeo ScientifiX’s stock symbol?
The ticker symbol for Zeo ScientifiX is ZEOX.
-
What is the current stock price of Zeo ScientifiX?
As of 13-Nov-2026 the stock price of Zeo ScientifiX is $0.80.
-
What is the current market cap of Zeo ScientifiX?
The current market capitalization of Zeo ScientifiX is $6.24M.
-
What is Zeo ScientifiX’s current revenue?
The trailing twelve month revenue for Zeo ScientifiX is $6.99M.
-
Who are Zeo ScientifiX’s competitors?
Kimera Labs, Alector, Denali Therapeutics, Invitrx Therapeutics, and Direct Biologics are competitors of Zeo ScientifiX.
-
What is Zeo ScientifiX’s annual earnings per share (EPS)?
Zeo ScientifiX’s EPS for 12 months was -$0.58.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
